Clinical Trial Update: Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus an EGFR monoclonal antibody for colorectal cancer with liver metastases is not yet recruiting. The protocol …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EGFR monoclonal antibody (unspecified)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Liver Metastases of Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING